Taiwan · Delayed Price · Currency is TWD Synbio Tech Statistics
Total Valuation
Synbio Tech has a market cap or net worth of TWD 1.60 billion. The enterprise value is 2.94 billion.
| Market Cap | 1.60B |
| Enterprise Value | 2.94B |
Important Dates
The next estimated earnings date is Wednesday, November 11, 2026.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | Mar 27, 2026 |
Share Statistics
Synbio Tech has 34.48 million shares outstanding. The number of shares has increased by 8.69% in one year.
| Current Share Class | 34.48M |
| Shares Outstanding | 34.48M |
| Shares Change (YoY) | +8.69% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 31.16% |
| Owned by Institutions (%) | n/a |
| Float | 14.73M |
Valuation Ratios
The trailing PE ratio is 11.28.
| PE Ratio | 11.28 |
| Forward PE | n/a |
| PS Ratio | 1.59 |
| PB Ratio | 1.22 |
| P/TBV Ratio | 1.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 8.71 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 20.73 |
| EV / Sales | 2.93 |
| EV / EBITDA | 12.10 |
| EV / EBIT | 22.61 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.09, with a Debt / Equity ratio of 1.26.
| Current Ratio | 1.09 |
| Quick Ratio | 0.51 |
| Debt / Equity | 1.26 |
| Debt / EBITDA | 6.79 |
| Debt / FCF | -5.68 |
| Interest Coverage | 4.39 |
Financial Efficiency
Return on equity (ROE) is 11.21% and return on invested capital (ROIC) is 4.90%.
| Return on Equity (ROE) | 11.21% |
| Return on Assets (ROA) | 2.72% |
| Return on Invested Capital (ROIC) | 4.90% |
| Return on Capital Employed (ROCE) | 5.45% |
| Weighted Average Cost of Capital (WACC) | 4.35% |
| Revenue Per Employee | 10.94M |
| Profits Per Employee | 1.54M |
| Employee Count | 92 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 2.02 |
Taxes
In the past 12 months, Synbio Tech has paid 9.05 million in taxes.
| Income Tax | 9.05M |
| Effective Tax Rate | 5.99% |
Stock Price Statistics
The stock price has decreased by -64.37% in the last 52 weeks. The beta is 0.52, so Synbio Tech's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -64.37% |
| 50-Day Moving Average | 47.77 |
| 200-Day Moving Average | 68.03 |
| Relative Strength Index (RSI) | 46.20 |
| Average Volume (20 Days) | 45,221 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Synbio Tech had revenue of TWD 1.01 billion and earned 142.06 million in profits. Earnings per share was 4.11.
| Revenue | 1.01B |
| Gross Profit | 503.48M |
| Operating Income | 130.21M |
| Pretax Income | 151.11M |
| Net Income | 142.06M |
| EBITDA | 239.93M |
| EBIT | 130.21M |
| Earnings Per Share (EPS) | 4.11 |
Balance Sheet
The company has 305.47 million in cash and 1.65 billion in debt, with a net cash position of -1.35 billion or -39.06 per share.
| Cash & Cash Equivalents | 305.47M |
| Total Debt | 1.65B |
| Net Cash | -1.35B |
| Net Cash Per Share | -39.06 |
| Equity (Book Value) | 1.31B |
| Book Value Per Share | 38.11 |
| Working Capital | 74.46M |
Cash Flow
In the last 12 months, operating cash flow was 183.48 million and capital expenditures -474.37 million, giving a free cash flow of -290.89 million.
| Operating Cash Flow | 183.48M |
| Capital Expenditures | -474.37M |
| Depreciation & Amortization | 109.72M |
| Net Borrowing | 382.78M |
| Free Cash Flow | -290.89M |
| FCF Per Share | -8.44 |
Margins
Gross margin is 50.02%, with operating and profit margins of 12.94% and 14.11%.
| Gross Margin | 50.02% |
| Operating Margin | 12.94% |
| Pretax Margin | 15.01% |
| Profit Margin | 14.11% |
| EBITDA Margin | 23.84% |
| EBIT Margin | 12.94% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 6.54%.
| Dividend Per Share | 3.00 |
| Dividend Yield | 6.54% |
| Dividend Growth (YoY) | -39.64% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 72.80% |
| Buyback Yield | -8.69% |
| Shareholder Yield | -2.15% |
| Earnings Yield | 8.89% |
| FCF Yield | -18.20% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 6, 2024. It was a forward split with a ratio of 1.02.
| Last Split Date | Aug 6, 2024 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
Synbio Tech has an Altman Z-Score of 1.68 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.68 |
| Piotroski F-Score | 4 |